A drug that could extend women’s fertility by five years – and help them live longer in better health – is safe for a young, healthy population, according to early results of a study.

The research into repurposing the immunosuppressant rapamycin has been hailed a “paradigm shift” in how menopause is studied.

The Validating Benefits of Rapamycin for Reproductive Aging Treatment (Vibrant) study is designed to measure whether the drug can slow ovaries ageing, thereby delaying menopause, extending fertility and reducing the risk of age-related diseases.

The study, which will eventually include more than 1,000 women, now has 34 participants aged up to 35, with more women joining every day.

  • pelletbucket@lemm.ee
    link
    fedilink
    English
    arrow-up
    4
    arrow-down
    1
    ·
    4 months ago

    now if only we had a world that felt like something safe to bring a child into

  • dandi8@fedia.io
    link
    fedilink
    arrow-up
    3
    arrow-down
    1
    ·
    edit-2
    4 months ago

    I’m sorry, the drug can extend women’s lifespan and improve their health, and what we’re choosing to focus on is their… fertility?

  • Beaver@lemmy.ca
    link
    fedilink
    English
    arrow-up
    3
    arrow-down
    2
    ·
    4 months ago

    Women deserve the same fertility window as men. I don’t want to receive more baby questions any more than anyone else.

      • Beaver@lemmy.ca
        link
        fedilink
        English
        arrow-up
        3
        arrow-down
        2
        ·
        4 months ago

        That’s a straw-man as I’m talking about the lack of investment into women’s health

        • pelletbucket@lemm.ee
          link
          fedilink
          English
          arrow-up
          3
          arrow-down
          2
          ·
          4 months ago

          and don’t go lecturing people about straw men if you didn’t bother explaining yourself.